Christophe Pichavant
Publications by Year
Research Areas
Muscle Physiology and Disorders, Virus-based gene therapy research, Tissue Engineering and Regenerative Medicine, CRISPR and Genetic Engineering, Cardiomyopathy and Myosin Studies
Most-Cited Works
- → Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD(2011)192 cited
- → Meganucleases can restore the reading frame of a mutated dystrophin(2010)74 cited
- → Incidence and severity of myofiber branching with regeneration and aging(2014)66 cited
- → Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress(2015)32 cited
- → Expression of Dog Microdystrophin in Mouse and Dog Muscles by Gene Therapy(2010)28 cited
- → Induction of Tolerance across Fully Mismatched Barriers by a Nonmyeloablative Treatment excluding Antibodies or Irradiation Use(2006)21 cited
- → Electrotransfer of the Full-Length Dog Dystrophin into Mouse and Dystrophic Dog Muscles(2010)19 cited
- → Creatine kinase B is necessary to limit myoblast fusion during myogenesis(2015)14 cited
- → DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B(2017)12 cited
- → Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy(2019)10 cited